- Overview
- Products
- Negative Pressure Wound Therapy
- Wound Dressings and Compression
- Skin Care
- Surgical
- Vascular Access
- Sterilization Monitoring
- Temperature Management
- Adhesive Securement
- Patient Monitoring
- Respiratory Protection
- Securement and Immobilization
- Prevention
- Pressure Injuries
- Adhesive Skin Damage
- Moisture Associated Skin Damage
- Bloodstream Infections
- Hypothermia
- Tube and Line Dislodgement
- Cross Contamination
- Electrode-Related Alarm Fatigue
- Hand Hygiene
- Treatment
- Pressure Injuries
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Traumatic Wounds
- Surgical Incisions
- Open Abdomen
- Incontinence-Associated Dermatitis
- Edema and Lymphedema
- Oncology Care
- C. difficile infection
- Resources
- Education
- Support
Understanding and Managing Incontinence-Associated Dermatitis
Incontinence-Associated Dermatitis (IAD) is a painful, problematic skin injury that results from exposure to urine or feces. This is a miserable patient experience that also increases the risk of complications, such as secondary infections and pressure ulcers or injuries.
Are your patients at risk?
Residents or patients with incontinence are at risk, but those with mixed incontinence are the most vulnerable — especially when stools are liquid or diarrhea is present.3
Examining the Impact of Incontinence-Associated Dermatitis
IAD is an issue in acute as well as long-term care settings. The data sheets below will help you measure and manage IAD's impact within your facility.
-
Explore the impact of Incontinence-Associated Dermatitis in acute settings (PDF, 449.53 KB).
Incontinence-Associated Dermatitis can cause patients considerable discomfort and can cost facilities a considerable amount of money. That’s what makes assessing and addressing IAD so important.
Explore Incontinence-Associated Dermatitis in long-term care settings (PDF, 354.26 KB).
Incontinence-Associated Dermatitis can cause discomfort, pain, burning or itching in the affected areas. A prevention protocol may reduce the risk (and associated costs) of resident skin damage.
In 2014, 3M brought together 20 international experts to look at gaps in Incontinence-Associated Dermatitis clinical care and to advance best practice principles that address those gaps. What will you find in their best practice principles document?
Hands-on clinicians will find practical guidance for:
- Assessing risk
- Preventing symptoms
- Managing Incontinence-Associated Dermatitis
Skin care is key to skin integrity.
3M™ Cavilon™ Skin Care Solutions – including our new, innovative 3M™ Cavilon™ Advanced Skin Protectant – provide all the products you need for prevention and management of skin damage, even in the case of category 2 (moderate to severe) Incontinence-Associated Dermatitis.
-
Dec 1, 1901is our revolutionary breakthrough barrier that protects patient skin for up to seven days.
-
Dec 1, 1901creates a durable, breathable barrier — without zinc oxide or petrolatum.
-
-
Discover what makes 3M™ Cavilon™ Advanced Skin Protectant powerful enough to end IAD with an in-person demonstration.
Learn even more about Incontinence-Associated Dermatitis.
-
Download a helpful resource that defines IAD and outlines what you can do about protection and prevention.
-
Hear what IAD experts have to say about the condition, as well as prevention and protection of patient skin.
-
This overview video highlights the Best Practice Principles outlined in Incontinence-Associated Dermatitis: Moving Prevention Forward.
-
3M℠ Health Care Academy
3M℠ Health Care Academy offers proven, practical online educational content to healthcare professionals. Explore available courses focused on Incontinence-Associated Dermatitis and other conditions.
Manage your training, test your knowledge, and receive certifications for completed courses.
1. Nix D, Haugen V (2010) Prevention and management of Incontinence-Associated Dermatitis. Drugs Aging 27(6); 491-6.
2. Gray M, Bartos S. Incontinence-Associated Dermatitis in the Acute Care Setting: A Prospective Multi-Site Epidemiological Study. Presented at the Symposium on Advanced Wound Care. May 2013.
3. Beekman D et al. Proceedings of the Global IAD Expert Panel. Incontinence-Associated Dermatitis: moving prevention forward. Best Practice Principles. Wound International 2015.
